Shared research and targets.

Fundamental analysis to support your decisions.

Learn from peer investors to counter your biases.

Track and monitor your investment decisions.

F

Flow Traders N.V.

Hold by Alpha

Flow Traders is an investment case to benefit from ETP growth and market turmoil. The company is doing well when volumes and volatility peak (like in Aug'24). After a €17 low the share price climbed to €21 in October benefiting from increased volatility. In November the VIX dropped significantly (after the election of Trump) to below 15. Market's sentiment about the (US) economy is currently positive. In this market annual earning should land around €2,50/share in 2024 and the share price has little upside potential. Flow Traders is however a long term hold as an insurance and for its venture assets.
  •  
  • 22.50 +3.12% by 05/08/2025
15/11/2024Analyses:8
0
F

Fortum Oyj

Hold by Alpha

Fortum is a defensive utilities investment in a quality company with a strong balance sheet. The company strategy is to focus on core business, and quickly divesting non-core assets. In the energy market Fortum is well positioned providing base-load and flexible energy capacity in the Scandinavian market. 90% of EBITDA results from 45TWh low CO2 hydro and nuclear power generation at competitive prices. Fortum is valued at 10x TTM earnings. The share is fairly priced with 8% dividend yield. The dividend return has the potential to grow based on the low debt level and strong cash position.
  •  
  • 15.00 +6.99% by 15/07/2025
30/10/2024Analyses:12
1
Centrus investment case is a bet on the revival of nuclear energy. This thesis is supported by recent announcements for nuclear power supply to data-centers. This US based supplier of LEU (>$200M) and enrichment technical services (>$100M), with customers in the US, Asia and Europe, operates the only facility licensed by the U.S. Nuclear Regulatory Commission (NCR) to produce HALEU (20% U-235). HALUE is the fuel required for many types of Small Modular Reactors (SMRs). Centrus is at least 5 years ahead of competition on High-Assay Low Enriched Uranium. Future demand for HALUE and the sanctions on Russian LEU (30% of US/EU demand) are multi-billion dollar growth opportunities for Centrus in the coming 10 years. The US government stimulates investments with RFPs for LEU (3.4B$) and HALUE (2.7B$) enrichment. Given the potential the company is undervalued at 20x PE ($80/est earnings 2024).
  •  
  • 100.00 +32.53% on 29/10/2024
29/10/2024Analyses:18
3
Q

Qliro AB (publ)

Buy by Alpha

Qliro is a growth opportunity within e-Commerce payments. The payment and check-out service provider turned profitable in 2023 and aims for (international) expansion. Qliro recently issued 50Mkr new shares to invest in further expansion. 2023-2024 results show that the company has good potential for long-term growth. The shares are priced 60x PE TTM. Increasing payment volumes from new merchants should result in a strong growth in EPS in 2024 and the coming years. Assuming continued growth the share has 60% upside potential (50x est. EPS 2024).
  •  
  • 44.00 +77.42% by 28/09/2025
29/10/2024Analyses:10
1
A company specializing in kraft paper for paper bags and packaging etc. and natural grease paper for the food industry. The company has been subject to a new major owner, SVP Strategic Value Partners, with about 48% of the shares. NordicPaper acquired a Canadian company which was included in the reporting from 2022Q. There are yearly seasonal effects from maintenance stops in Q3 at all Nordic Paper production plants. There are ongoing investments in Bäckhammar (about 500MSEK in 2024) which should be completed end of 2025, where after estimated to contribute 100MSEK/year in EBITDA. Energy costs should be lower for Q3, but ~70% hedged. The product volumes seem to be quite stable YoY. Raw material costs are significant part of the product price thus NordicPapers’s focus is mostly on margin. NordicPaper seem like a well managed company, with good profits in a stable market. It could be a good long term investment.
  •  
  • 54.00 +8.83% by 25/10/2025
25/10/2024Analyses:0
1
Autostore is a tech company within warehouse automation. They seem to have a very good system with good ROI for customers. Installations are done via integration partners and Autostore has many large installations. The company is listed in Oslo but the majority owners are in the US. Valuation was very high at the IPO 2021, driven by high growth within e-commerce during Covid. The growth outlook is now negative for 2024, if/when growth returns the share price will increase. The share isn’t cheap but at 11 NOK Autostore seems reasonably priced with good long term potential.
  •  
  • 12.50 +6.29% by 03/10/2025
03/10/2024Analyses:3
2
C

Commerzbank AG

Buy by micke

Commerzbank continues to deliver and repeat their plans to increase profits. I think Commerzbank’s result estimates are reasonable, looking back a few years their estimates have been conservative. Long term I think banks that are well run, such as Commerzbank, should be traded at P/E=10 or a bit higher on long term profits. The new CEO (former CFO) elaborated on 3 billion in profit and current market cap. (19 billion), there is room for higher share price. With these numbers I se a potential of 58%, in couple of years, share price from today’s €16 to €25. And we will be getting share buybacks and dividends on the way. Short term there can be high volatility, for example Uni-Credits interest in Commerzbank or not.
  •  
  • 20.00 +26.58% by 02/10/2025
02/10/2024Analyses:8
2
N

Norion Bank AB

Buy by Alpha

Norion is a niche bank focused on real-estate financing (50%) and SME (19%). As a niche player in the financial sector the company has better growth opportunities. The bank operates in segments with higher risks and higher margins. When well-managed this results in higher profit margins. The share is valued at <7x PE 2023 with >15% ROE. The company is undervalued at 0.5 PEG and is an attractive value investment (compared to the larger banks).
  •  
  • 52.00 +35.24% by 18/09/2025
18/09/2024Analyses:9
1
Bioarctic is a long-term growth investment into a bio-tech research company developing Alzheimer medication and other nervous system related medication. Its leading product LEQEMBI is a fast growing Alzheimer disease modification treatment. LEQEMBI sales are expected to turn BioArctic profitable in 2025. The company is valued at 14x PS 2025 and around 17x PE 2026. BioArctic is the market leader in AD, and has a portfolio with nervous system related treatments. I expect the price to recover above 200 in 2024 upon EU approval (after the recent 35% drop). In the longer term the share price has the potential to double (3-5 years).
  •  
  • 215.00 +20.72% by 01/03/2025
16/09/2024Analyses:11
1
A

ABN AMRO Bank N.V.

Monitor by Alpha

ABN is a Dutch bank with Retail banking, Wealth management and Corporate banking services in North-West Europe. Income comes mostly from NII, of which 90% in the Netherlands. A forward looking annual net profit of >€2B in 2024 gives a valuation of 6x PE at €12B market cap. 2024 results will depend on cost control and the interest rate climate. ABN is a buy with a 10% annual dividend yield (50% payout) plus €500M share buyback in 2024. And the low 0.6 PB ratio makes it an attractive investment.
  •  
  • 17.50 +18.00% by 01/03/2025
22/08/2024Analyses:8
3
Railcare is a defensive investment in infrastructure services for rail transport. At >15x PE the Swedish railroad services market potential is priced in. Recent analyst recommendations increased popularity with its effect on the share price. In the second half of 2024 I expect a 20% correction after strong share price development in the last 12 months. Especially as the Q2'24 results showed a significant drop in margins.
  •  
  • 24.00 -12.41% by 01/03/2025
15/08/2024Analyses:7
2